UDG Healthcare to acquire Cambridge BioMarketing for up to $35m

International healthcare services provider UDG Healthcare has agreed to acquire US-based healthcare communications business Cambridge BioMarketing for a total consideration of up to $35m.

Source: Pharmaceutical Technology - July 17, 2017 Category: Pharmaceuticals Source Type: news